| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268416A1 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses |
| 01/02/2003 | EP1268415A1 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds |
| 01/02/2003 | EP1268407A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/02/2003 | EP1268404A1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2003 | EP1268096A1 Extrusion die |
| 01/02/2003 | EP1267954A1 Medical devices suitable for gene therapy regimens |
| 01/02/2003 | EP1267931A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 01/02/2003 | EP1267921A1 Composition and method for the prevention and/or the treatment of allergy |
| 01/02/2003 | EP1267915A2 Methods of treating diseases with activated protein c |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267902A1 Cosmetic use of hop and ornithine |
| 01/02/2003 | EP1267900A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 01/02/2003 | EP1267888A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 01/02/2003 | EP1267875A1 Sigma receptor ligands and their medical uses |
| 01/02/2003 | EP1267870A2 Inhibition of cytokine generation |
| 01/02/2003 | EP1267868A2 Inhibitors of melanocyte tyrosinase as topical skin lighteners |
| 01/02/2003 | EP1267859A2 Treatment of psoriasis |
| 01/02/2003 | EP1267850A2 Compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267822A2 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 01/02/2003 | EP1267808A2 Compositions and methods for treating hair loss using oximyl- and hydroxylamino- prostaglandins |
| 01/02/2003 | EP1267807A2 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 01/02/2003 | EP1267806A2 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| 01/02/2003 | EP1267803A2 Compositions and methods for treating hair loss using c 16? - c 20? aromatic tetrahydro prostaglandins |
| 01/02/2003 | EP1267800A1 Methods of modulating hair growth |
| 01/02/2003 | EP1267798A1 Treatment of skin damage using polyenylphosphatidylcholine |
| 01/02/2003 | EP1267616A1 Methods of modulating hair growth |
| 01/02/2003 | EP1146844B1 Membrane lipid compositions |
| 01/02/2003 | EP1113798B1 Topical formulation of alkyl-, phenyl-pyridone |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/01/2003 | CN1387906A Qianqianxuan Chinese medicine capsule |
| 01/01/2003 | CN1387899A Externally applied ointment for treating burns and its prepn |
| 01/01/2003 | CN1387895A Medicine liquid for treating burns and scalds |
| 01/01/2003 | CN1387881A Externally applied Chinese medicine oil prepn for treating burns and scalds |
| 01/01/2003 | CN1387879A Fase nursing and beautifying oral liquid and its prepn |
| 01/01/2003 | CN1387857A Fibroblast growth promoter and its application |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 01/01/2003 | CN1097452C Skin spraying sterilizing agent |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis |
| 12/31/2002 | US6500864 Disulfide derivatives useful for treating allergic diseases |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500835 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 12/31/2002 | US6500470 Use of at least one protein extract of the moringa genus plant seeds and corresponding cosmetic and/or pharmacological composition |
| 12/31/2002 | US6500460 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 12/31/2002 | US6500441 Single-phase transparent aqueous cosmetic composition |
| 12/31/2002 | US6500427 One-component tissue adhesive and a process for the production thereof |
| 12/31/2002 | US6500411 A particulate material and a natural polymer free of carboxymethyl cellulose or xanthan gum for addtion to a formulation including a hydrophilic liquid selected from water, a hydrophilic organic liquid, and mixture; sunscreen |
| 12/31/2002 | US6500183 Microdermabrasion device |
| 12/31/2002 | CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability |
| 12/31/2002 | CA2029524C Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole |
| 12/27/2002 | WO2002103351A1 Method of detecting skin stimulation effect |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103027A1 Glycoprotein and process for producing the same |
| 12/27/2002 | WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/27/2002 | WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102845A1 Process for producing silk fibroin-origin functional polypeptide and utilization thereof |
| 12/27/2002 | WO2002102808A2 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR |
| 12/27/2002 | WO2002102805A1 NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS |
| 12/27/2002 | WO2002102804A1 New use of specific cyclolignans |
| 12/27/2002 | WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 12/27/2002 | WO2002102771A1 Tryptase inhibitors |
| 12/27/2002 | WO2002102411A2 Method for treating psoriasis by using an il-17d antagonist |
| 12/27/2002 | WO2002102406A1 Use of glycoprotein for the treatment and re-epithelialisation of wounds |
| 12/27/2002 | WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | WO2002102371A1 Use of ascorbic acid for producing topical preparations with angiogenetic effects |
| 12/27/2002 | WO2002102352A1 Composition for the treatment of diseases which affect animals' hooves |
| 12/27/2002 | WO2002102346A1 Use of at least one 10-hydroxy-2-decenoic acid derivative in compositions for treating the cutaneous signs of ageing |
| 12/27/2002 | WO2002102344A2 No-synthase inhibitor and use thereof |
| 12/27/2002 | WO2002102343A1 Ascorbyl 2-hexadecanoate as a no-synthase inhibitor |
| 12/27/2002 | WO2002102340A2 Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations |
| 12/27/2002 | WO2002102338A1 Carnitine and acyl-carnitines used in the treatment and prophylaxis of pigmentation disorders |
| 12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002102304A2 Gum resin as a carrier for topical application of pharmacologically active agents |
| 12/27/2002 | WO2002087626A9 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same |
| 12/27/2002 | WO2002083696A3 Novel cyclo azaphospha hydrocarbons |
| 12/27/2002 | WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain. |
| 12/27/2002 | WO2002072047A3 Cosmetic or pharmaceutical agent |
| 12/27/2002 | WO2002069989A3 Aquatic animal treatment method and composition containing pimenta extract |
| 12/27/2002 | WO2002069911A3 Active substance combination consisting of $g(a)-liponic acid and bioquinones |
| 12/27/2002 | WO2002060922A3 Epoxyvibsanin b |
| 12/27/2002 | WO2002056874A3 Lipid-based nitric oxide donors |
| 12/27/2002 | WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |